WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV

Mark Identification

Proof of use for BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV

We do not have any records of a proof of use for BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV at this moment.

Click here to add a proof of use for BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV

Possible trademark infringements of BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV

Basic Information about BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV

Serial Number
97715574
Filing Date
13 Dec 2022
Mark Drawing Code
3

Classifications

Declare the trademark use of BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV on the blockchain with WikiTrademarks.io.

First use of BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV anywhere
BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV was first used on 12 Jun 2023 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
005
US Codes
005; 006; 018; 044; 046; 051; 052

Who owns BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV?

1. TG THERAPEUTICS, INC. New York NY

2. TG THERAPEUTICS, INC. New York NY

Correspondent

Maury M. Tepper, III TEPPER & EYSTER, PLLC
3724 BENSON DR
RALEIGH, NC 27609
United States

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV